Atle Fund Management AB Diversified Active

Location: Stockholm, Sweden

CIK: 0001381843 · Show all filings

Period: Q1 2016 (← Previous) (Next →)

Filing Date: Apr 19, 2016

Total Value: $214M (100.0% shares, 0.0% debt)

Holdings (18)

ANIK ANIKA THERAPEUTICS INC 10.3%

Value $21.93M Shares 490,331 Est. Cost $38.50 Unrealized +5.4%

— FEI CO 10.0%

Value $21.33M Shares 239,609 Est. Cost $82.13 Unrealized —

— LIFEPOINT HEALTH INC 8.9%

Value $19M Shares 274,430 Est. Cost $67.19 Unrealized —

— GNC HLDGS INC 8.7%

Value $18.64M Shares 586,955 Est. Cost $31.02 Unrealized —

— AMAG PHARMACEUTICALS INC 8.1%

Value $17.33M Shares 740,585 Est. Cost $28.17 Unrealized —

SUPN SUPERNUS PHARMACEUTICALS INC 6.5%

Value $13.78M Shares 903,533 Est. Cost $17.80 Unrealized -26.7%

CRL CHARLES RIV LABS INTL INC 6.3%

Value $13.54M Shares 178,307 Est. Cost $63.72 Unrealized +16.2%

— TARO PHARMACEUTICAL INDS LTD 6.3%

Value $13.47M Shares 94,005 Est. Cost $143.25 Unrealized —

— INC RESH HLDGS INC 6.3%

Value $13.36M Shares 324,270 Est. Cost $41.21 Unrealized —

MRK MERCK & CO INC NEW 6.2%

Value $13.3M Shares 251,400 Est. Cost $36.03 Unrealized 0.0%

ELV ANTHEM INC 6.1%

Value $13.05M Shares 93,900 Est. Cost $119.87 Unrealized -2.8%

— TRIPLE-S MGMT CORP 5.9%

Value $12.53M Shares 503,826 Est. Cost $19.58 Unrealized —

— VALEANT PHARMACEUTICALS INTL 4.6%

Value $9.731M Shares 370,000 Est. Cost $26.30 Unrealized —

— SYMMETRY SURGICAL INC 1.5%

Value $3.12M Shares 316,427 Est. Cost $8.67 Unrealized —

OSUR ORASURE TECHNOLOGIES INC 1.4%

Value $2.934M Shares 405,771 Est. Cost $6.36 Unrealized 0.0%

— DEPOMED INC 1.3%

Value $2.786M Shares 200,000 Est. Cost $13.93 Unrealized —

— SCICLONE PHARMACEUTICALS INC 1.2%

Value $2.599M Shares 236,288 Est. Cost $11.00 Unrealized —

ICCC IMMUCELL CORP 0.5%

Value $1.153M Shares 168,323 Est. Cost $5.29 Unrealized +26.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
ANIK	ANIKA THERAPEUTICS INC	490,331	$21.93M	10.3%	$38.50	+5.4%	COM	035255108
—	FEI CO	239,609	$21.33M	10.0%	$82.13	—	COM	30241L109
—	LIFEPOINT HEALTH INC	274,430	$19M	8.9%	$67.19	—	COM	53219L109
—	GNC HLDGS INC	586,955	$18.64M	8.7%	$31.02	—	COM CL A	36191G107
—	AMAG PHARMACEUTICALS INC	740,585	$17.33M	8.1%	$28.17	—	COM	00163U106
SUPN	SUPERNUS PHARMACEUTICALS INC	903,533	$13.78M	6.5%	$17.80	-26.7%	COM	868459108
CRL	CHARLES RIV LABS INTL INC	178,307	$13.54M	6.3%	$63.72	+16.2%	COM	159864107
—	TARO PHARMACEUTICAL INDS LTD	94,005	$13.47M	6.3%	$143.25	—	SHS	M8737E108
—	INC RESH HLDGS INC	324,270	$13.36M	6.3%	$41.21	—	CL A	45329R109
MRK	MERCK & CO INC NEW	251,400	$13.3M	6.2%	$36.03	0.0%	COM	58933Y105
ELV	ANTHEM INC	93,900	$13.05M	6.1%	$119.87	-2.8%	COM	036752103
—	TRIPLE-S MGMT CORP	503,826	$12.53M	5.9%	$19.58	—	CL B	896749108
—	VALEANT PHARMACEUTICALS INTL	370,000	$9.731M	4.6%	$26.30	—	COM	91911K102
—	SYMMETRY SURGICAL INC	316,427	$3.12M	1.5%	$8.67	—	COM	87159G100
OSUR	ORASURE TECHNOLOGIES INC	405,771	$2.934M	1.4%	$6.36	0.0%	COM	68554V108
—	DEPOMED INC	200,000	$2.786M	1.3%	$13.93	—	COM	249908104
—	SCICLONE PHARMACEUTICALS INC	236,288	$2.599M	1.2%	$11.00	—	COM	80862K104
ICCC	IMMUCELL CORP	168,323	$1.153M	0.5%	$5.29	+26.0%	COM PAR $0.10	452525306